Speaker: Prof. Dr. Klaus Kopka
Organizer: HIRO, OncoRay and DKTK
Registration necessary: yes
OBJECTIVES OF THE LECTURE SERIES
Radiation research and radiotherapy in oncology are highly interdisciplinary fields: physicians, scientists like biologists and physicists as well as engineers and computer experts are closely collaborating within the Heidelberg Institute of Radiation Oncology (HIRO) and OncoRay in Dresden.
The established cooperation of HIRO and OncoRay was awarded by BMBF as the National Center for Radiation Research in Oncology (NCRO).
To train young scientists in interdisciplinary research work is a special responsibility of HIRO, DKFZ and OncoRay. An important condition for a fruitful scientific collaboration is an active communication between researchers and consequently a common knowledge of the fundamentals of the whole field. This will be supported by this series of 18 lectures in 2 years.
The lectures cover a wide spectrum of topics from medicine, biology, chemistry, physics and technology being relevant for the research at HIRO Heidelberg and OncoRay Dresden. Each lecture will give a commonly understandable overview on a particular topic.
Therefore, all PhD students of the DKFZ, the Heidelberg university hospital and OncoRay as well as collaborating institutions and all other interested persons are cordially invited to join the lectures!
TOPIC OF THIS EVENT
Radiopharmaceuticals are radiolabelled drugs usually administered in Nuclear Medicine clinics for diagnosis by means of non-invasive PET/CT, PET/MRI and SPECT/CT imaging or for systemic internal therapy, nowadays called targeted endoradiotherapy. The (historic) radiotracer/radioindicator principle at the moment experiences a renaissance by the clinically introduced classes of theranostic radiotracers, which enable highly sensitive and selective imaging of receptors/proteins abnormally upregulated in a given disease (e.g. cancer). This imaging approach is needed to justify and to assess the probability of successful targeted treatment by endoradiotherapy, using the same class of tracer molecules. This lecture will reflect the radiotracer principle using the class of theranostic radioligands. The complexity will be addressed how to combine diagnosis and therapy in Nuclear Medicine with one and the same class of tracer molecule.